Inequitable access to COVID-19 vaccines has turned out to be the catastrophic moral failure the World Health Organization's director-general warned about at the beginning of 2021.
Aug 30, 2022
0
13
Moderna said Friday it is suing rival vaccine makers Pfizer and BioNTech, alleging the partners infringed on its patents in developing their COVID-19 shot administered to hundreds of millions around the world.
Aug 26, 2022
0
30
A stretch of DNA that hops around the human genome plays a role in premature aging disorders, scientists at the Salk Institute and King Abdullah University of Science and Technology (KAUST) in Saudi Arabia have discovered. ...
Aug 10, 2022
0
93
A new clinical-grade collagen made from discarded bullfrog skin is leapfrogging from the lab bench to clinics soon.
Jul 27, 2022
0
5
In a policy statement issued by the American Academy of Pediatrics and published online July 18 in Pediatrics, guidance is presented for the management of visual disorders following a concussion among children.
Jul 18, 2022
0
2
German pharmaceutical company CureVac said Tuesday it was suing rival BioNTech for patent infringement over the mRNA technology used to develop the Comirnaty coronavirus vaccine.
Jul 5, 2022
0
2
Researchers at the University of California San Diego and the Salk Institute for Biological Studies have developed a tiny neural probe that can be implanted for longer time periods to record and stimulate neural activity, ...
Jun 9, 2022
0
89
A University of Georgia nanotechnology research group entered the race to develop a rapid test for COVID-19 in August 2020, running experiments on a new sensor for an American manufacturing company. The group, led by Yiping ...
Apr 7, 2022
0
17
The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...
Apr 6, 2022
0
15
Discovering new ways to use existing drugs can come about intentionally or by chance.
Apr 6, 2022
0
2
